First half 2019 results presentation

Operating income, growth figures, profitability and how our products have behaved


No votes yet
 
Related
  Madrid - January 28, 2022 Last May, ROVI signed a financing agreement with the Centre for Industrial Technological Development...
1 min
28/01/2022
ROVI recibe la opinión positiva del CHMP para Okedi® como tratamiento de la esquizofrenia
Laboratorios Farmacéuticos Rovi, a pan-European pharmaceutical company specializing and engaging in the research, development, contract...
4 min
17/12/2021
2021 Capital Markets Day presentation
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION (COMISIÓN NACIONAL DEL MERCADO DE VALORES) Madrid, 16 November 2021 In...
1 min
16/11/2021